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Abstract
Leukocyte telomere length (LTL) might be causal in cardiovascular disease and major cancers. To elucidate the roles of
genetics and geography in LTL variability across humans, we compared LTL measured in 1295 sub-Saharan Africans (SSAs)
with 559 African–Americans (AAms) and 2464 European–Americans (EAms). LTL differed significantly across SSAs
(P = 0.003), with the San from Botswana (with the oldest genomic ancestry) having the longest LTL and populations from
Ethiopia having the shortest LTL. SSAs had significantly longer LTL than AAms [P = 6.5(e-16)] whose LTL was significantly
longer than EAms [P = 2.5(e-7)]. Genetic variation in SSAs explained 52% of LTL variance versus 27% in AAms and 34% in
EAms. Adjustment for genetic variation removed the LTL differences among SSAs. LTL genetic variation among SSAs, with
the longest LTL in the San, supports the hypothesis that longer LTL was ancestral in humans. Identifying factors driving LTL







g/article/29/18/3014/5894947 by guest on 17 D
ecem
ber 2020
Human Molecular Genetics, 2020, Vol. 29, No. 18 3015
Introduction
Telomere length (TL) undergoes age-dependent shortening in
replicative somatic cells starting in utero (1). Epidemiological
studies have used leukocyte TL (LTL) as a proxy of TL in other
somatic tissues (2), and many researchers concluded that it is
a passive biomarker of human aging and adult-onset diseases
(3). Recent findings suggest, however, that LTL is a component
in a causal pathway in such diseases. Several lines of evidence
support this inference, including findings that LTL is largely
determined at birth and in early childhood (1,4). Consequently,
individuals who enter adulthood with comparatively long or
short LTL typically have long or short TL throughout the rest of
their lives (5). Thus, the risk of adult-onset diseases associated
with long or short TL is often defined decades before overt
manifestations of disease (6). In addition, genome-wide asso-
ciation studies have identified LTL-associated single-nucleotide
polymorphisms (SNPs), the majority of which map to loci that
harbor telomere maintenance genes (7–9). These loci have been
used to infer, through Mendelian randomization analyses, a
causal role of long telomeres in major cancers and short telom-
eres in atherosclerotic cardiovascular disease (10,11), the two
disease categories that largely define longevity in middle- and
high-income countries.
African–Americans (AAms) have longer LTL (12–16) and are
less susceptible to atherosclerotic cardiovascular disease than
individuals of European ancestry (16). In addition, a study of a
small sample of Tanzanians, AAms and European–Americans
(EAms) found longer LTL in Africans from Tanzania than in the
other populations (14). The study also showed that the shifts
in allele frequency between sub-Saharan Africans (SSAs) and
individuals of European ancestry do not fit the pattern expected
by neutral genetic drift of loci that affect LTL. This observation
is consistent with the conclusion that TL is a target of selection,
and that polygenic adaptation that contributes to differences in
frequency of LTL-associated alleles in globally diverse popula-
tions can drive population variation in LTL (14). These findings
demonstrate that to better understand adult-onset disease dis-
parities across continental populations, we need to know more
about the factors influencing LTL variation in diverse popula-
tions. The aim of this study was to estimate the diversity of and
genetic contributions to LTL across a diverse set of sub-Saharan
populations and test whether or not population differences in
LTL can be explained by these genetic effects.
Results
LTL was measured by Southern blotting in 1295 SSAs from
seven populations defined by geography (Botswana, Tanzania
and Ethiopia) and genetically inferred ancestry (hereafter,
referred to as ‘ancestry’) (17). These include hunter–gatherer
populations (Khoisan-speaking San from Botswana and Hadza
from Tanzania), pastoralists (Nilo-Saharan-speaking popula-
tions from Ethiopia and Herero from Botswana), agriculturalists
(Bantu-speaking populations from Tanzania and Botswana)
and agro-pastoralists (Afroasiatic-speaking populations from
Ethiopia and Tanzania). Adults were randomly sampled from
the different populations and lived in mostly rural areas
practicing indigenous lifestyles. We compared LTL findings in
these populations to 559 AAms and 2464 EAms from the Family
Heart Study (12) with available genotypes for kinship estimation
and LTL measurements for direct comparisons of LTL in SSA
populations. AAms resided in Alabama and North Carolina, and
EAms resided in Massachusetts, Minnesota, North Carolina and
Utah.
We focused on whether the effects of genetics, age and sex
on LTL explain the population differences in mean and variance
of LTL. SSAs had significantly longer sex- and age-adjusted LTL
than AAms [difference = 0.47 ± 0.06 kilobase pairs (kb), P = 6.5(e-
16)], and AAms had significantly longer adjusted LTL than EAms
[difference = 0.19 ± 0.04 kb, P = 2.5(e-7)] (Table 1). The sex- and
age-adjusted LTL variances were significantly different among
the three groups [Levene’s test for homogeneity, P = 2.2(e-14)].
The San population in Botswana showed the longest age- and
sex-adjusted LTL (P < 0.001 versus each of the other six SSA pop-
ulations; P = 0.003 for the overall test of mean differences among
all SSA populations; Table 1). The two ancestries in Ethiopia had
the shortest adjusted LTL, and those with an Afroasiatic ancestry
living in Ethiopia had shorter LTL than those living in Tanzania
[difference = 0.26 ± 0.06 kb, P = 2.7(e-6)]. There was no significant
difference in LTL between the Bantu-speaking populations in
Botswana versus Tanzania (difference = 0.10 ± 0.08 kb, P = 0.23).
These observations are consistent with a north–south gradient
of increasing LTL.
Sex-adjusted LTL decreased with age at a rate of
−0.023 ± 0.0010 kb/year in SSAs [P = 1.8(e-114); Fig. 1]. The rate
of decrease did not differ by SSA ancestral groups (P = 0.15).
Within each ancestry group, all age regression coefficients
with LTL were also significant. The age regression coefficient
for sex-adjusted LTL in AAms was −0.024 ± 0.0022 [P = 4.8(e-
28)] and in EAms was −0.022 ± 0.0009 [P = 2.4(e-126)]. The age
regression coefficients were not significantly different from one
another in a test for interaction across the three populations
(P = 0.61).
SSA women had longer age-adjusted LTL than men, with
a difference of 0.164 ± 0.039 kb [7.477 ± 0.054 kb in males and
7.642 ± 0.049 kb in females, P = 2.2(e-05); individual population
LTL differences by sex shown in Fig. 2]. For AAms and EAms,
the LTL differences by sex were 0.266 ± 0.052 [P = 2.7(e-7)] and
0.159 ± 0.021 [P = 1.7(e-14)], respectively. There was no interaction
between sex and ancestry in SSAs (P = 0.64), and there was no
interaction of the sex differences in LTL among SSAs, AAms and
EAms (P = 0.16).
The regression of LTL on age and sex explained 18% of the
inter-individual variance of LTL in SSAs (Table 2). The total
genetic variance of LTL, estimated using a linear mixed model
with kinship coefficients derived from SNP data and after
accounting for variation due to age and sex, represented an
additional 52% of the total LTL variance [P < 1(e-200)]. Variation
among the means of the seven SSA populations explained
10% additional variance of LTL [inter-ancestry genetic variance,
P = 7.2(e-23)]; therefore, the remaining 42% was derived from
intra-ancestral group genetic variance. Adjustment for the
genetic variance of LTL in SSAs removed the significance of
the mean LTL differences among the genetically inferred SSA
ancestry groups (P = 0.45).
Table 2 shows that the percent of variation explained by
age and sex was similar for SSAs, AAms and EAms (17–19%).
The genetic variance of age- and sex-adjusted LTL in SSAs was
almost twice as large as in AAms (52 versus 27%) and just over
50% greater than in EAms (52 versus 34%).
The effects of adjustment of LTL for genetic variance for each
SSA ancestry group are shown in Figure 3. Adjustment for the
genetic variance of LTL had the largest effect on the mean LTL of
the San population in Botswana and made the LTL means across
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Table 1. Age- and sex-adjusted leukocyte telomere length means (±SEM) by country and ancestry
Population LTL (kb) Female (%) Age (years)
European–Americans (N = 2464) 6.90 ± 0.02∗ 54.6 57.2 ± 13.3
African–Americans (N = 559) 7.09 ± 0.03∗ 66.2 53.3 ± 11.0
Sub-Saharan Africans (N = 1295) 7.56 ± 0.05∗ 52.6 39.4 ± 16.2
Ethiopia (N = 445) 7.38 ± 0.04 44.7 36.8 ± 14.3
Nilo-Saharan (N = 124) 7.35 ± 0.03 38.7 30.7 ± 11.3
Afroasiatic (N = 321) 7.41 ± 0.06 47.0 39.1 ± 14.6
Tanzania (N = 491) 7.59 ± 0.06 52.3 41.8 ± 17.5
Afroasiatic (N = 138) 7.67 ± 0.03 65.2 44.5 ± 15.5
Hadza (N = 246) 7.51 ± 0.05 48.0 40.8 ± 18.7
Bantu (N = 107) 7.45 ± 0.06 45.8 40.7 ± 16.8
Botswana (N = 359) 7.74 ± 0.07 62.7 39.5 ± 16.1
Bantu (N = 115) 7.55 ± 0.06 73.0 37.8 ± 15.0
San (N = 244) 7.89 ± 0.06† 57.8 40.3 ± 16.6
SEM, standard error of the mean; LTL, leukocyte telomere length.
LTL adjusted for sex, age and intra-population LTL correlations using generalized estimating equations.
∗P < 0.0001 for each of the three pairwise comparisons of the European–American, African–American and sub-Saharan African populations.
†P < 0.001 for each comparison of LTL in San versus the other six sub-Saharan populations.
Figure 1. Association of leukocyte telomere length (LTL) with age for each ancestry (adjusted for sex). Linear regression lines of age versus LTL for each inferred ancestry
are superimposed over the individual observations (N = 1295).
Table 2. Percent of leukocyte telomere length (LTL) variation (variance estimate in kb) explained by age, sex and genetics in the three study
populations
Source of LTL variation Sub-Saharan Africans African–Americans European–Americans
Age 17% (0.113) 15% (0.062) 15% (0.066)
Sex (age-adjusted) 1% (0.007) 4% (0.015) 2% (0.008)
Genetics (age- and sex-adjusted) 52% (0.342) 27% (0.110) 34% (0.153)
Full model (age, sex and genetics) 71% (0.462) 46% (0.187) 51% (0.227)
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Figure 2. Sex differences in leukocyte telomere length (LTL) by ancestry (adjusted for age). Error bars are standard errors of the mean (N = 1295).
Figure 3. Leukocyte telomere length (LTL) by ancestry. LTL is shown adjusted for age and sex, and adjusted for age, sex and LTL genetic variance. The genetic variance–
covariance structure of LTL was estimated using a kinship matrix calculated from identity-by-decent probabilities and using the estimated additive genetic variance,
both derived using a genome-wide single-nucleotide polymorphisms array. Error bars are standard errors of the least square means (N = 1295).
Discussion
The key findings of this work are LTL in the San hunter–gatherers
is longer than in other SSA populations, whose LTL is longer than
in AAms and EAms (14). Coupled with findings of longer LTL
in Hominidae (great apes) than humans (18,19), these findings
are consistent with the hypothesis that LTL in ancestral humans
was longer than in contemporary humans. Although SSAs have
longer LTL than AAms and EAms (14), they share two important
LTL-related features with non-Africans: a sex effect (4,5,20,21),
which in non-Africans is already observed in newborns (no
information is available at present on LTL in SSA newborns) (4),
and a similar rate of age-dependent LTL shortening in adults







g/article/29/18/3014/5894947 by guest on 17 D
ecem
ber 2020
3018 Human Molecular Genetics, 2020, Vol. 29, No. 18
replications of hematopoietic stem cells/progenitor cells (22,23).
The consistency of the sex and age associations with LTL across
adult populations living in different environmental conditions
indicates that LTL differences among ancestry groups are largely
independent of adult age and sex.
The total LTL variation and the genetic variance component
of LTL estimated from SNP data in SSAs was larger than in the
North American populations. The larger genetic variation may
result from larger SNP effect sizes, altered allele frequencies or
different genes responsible for LTL variation than in the other
two populations. Importantly, adjustment for the genetic effects
reduced the SSA residual LTL variance so that it was similar to
the residual variance in AAms and EAms and removed the SSA
population differences in mean LTL. Similarly, in the US Health
and Retirement Study, the significant LTL difference between
AAms and EAms was removed after adjusting for genetically
derived principal components (15). The equalization of either the
LTL variances or means in the two studies after adjustment for
the genetic contribution to LTL suggests that genetics is the main
determinant of variation in LTL among populations.
It is not clear why the SNP-estimated genetic variation of
LTL in AAms is not intermediate between the SSAs and EAms.
Despite the variation of the AAms being similar to EAms, it
does not mean that the same variants or genes explain inter-
individual LTL variation within and across the groups. In addi-
tion, most AAm ancestry is from western or south-western
Africa, whereas the SSAs of this study are eastern and southern
Africans. Other factors also influence LTL beyond age, sex and
genetics, and these, operating in quite different environments
in Africa and the USA, may contribute to the lower variance
estimates observed in AAms.
In previous work we proposed that in the course of the north-
bound migration out of Africa, Europeans experienced poly-
genetic adaptation that contributed to the shortening of their
LTL, perhaps attenuating the increased risk of individuals with
de-pigmented skin to sporadic melanoma (14). Although this
finding explains in part the shorter LTL in EAms, the precise
evolutionary explanation for the persistence of long LTL in SSA
populations is not understood. That said, birds with long telom-
eres display better survival when infected with avian malaria
(24), and acute Plasmodium falciparum malaria infection increases
the rate of LTL shortening in humans (25). Having long telomeres
might thus be advantageous in surviving malaria and other viral
and parasitic infections, further supporting the concept that LTL
is the target of selection.
Finally, we acknowledge the following limitations of our
study. First, the inclusion of newborns, children and individ-
uals from populations in central and western Africa would
provide a more comprehensive picture of LTL in SSAs. Second,
measurements of mean LTL for this study and for the Family
Heart Study were performed more than a decade apart, but were
measured by an identical technique (26) performed in the same
laboratory. Moreover, the same laboratory performed parallel
LTL measurements and generated similar findings in samples
from the Family Heart Study and from SSAs in a small study that
provided the foundation for this work (14).
In conclusion, SSAs, who have the highest degree of genetic
diversity (27), have on average a longer and more variable
LTL than non-Africans. Optimal LTL in a population may be
determined by pleiotropic telomere maintenance genes for a
given, but as of yet unknown, environmental setting. Throughout
human history, the characteristics and function of these genes
may have been forged by past genetic/environmental forces that
may not hold for modern populations. A possible outcome of LTL
pleiotropy is that modern populations with long LTL experience
higher rates of major cancers and populations with short LTL
experience higher rates of atherosclerotic cardiovascular disease
(10,11). Our findings call for intense research for the ramification
of a longer LTL in SSAs in the context of their propensities for
cancers and atherosclerotic cardiovascular disease. Insight into
the genetic contributions that have maintained a longer LTL
in SSAs will have, therefore, considerable ramifications from
the standpoint of telomere-mediated cancer–atherosclerosis
trade-off in humans (28).
Materials and Methods
Study design and participants
Mean LTL in SSAs was measured by Southern blotting of the ter-
minal restriction fragments (26). All samples, measured in dupli-
cate, passed a DNA integrity test before LTL measurements were
obtained. The inter-assay intra-class correlation from duplicate
measurements was 0.98 (0.91–1.0). We compared mean LTL find-
ings in these populations to 559 AAms and 2464 EAms from
the Family Heart Study (12). Identical LTL measurements were
performed in the same laboratory for the present study and the
Family Heart Study.
Adult participants were randomly recruited from each
village. Written informed consent was obtained from all par-
ticipants and research/ethics approval and permits were
obtained from the following institutions prior to sample
collection: The University of Pennsylvania, COSTECH, NIMR and
Muhimbili University of Health and Allied Sciences in Dar es
Salaam, Tanzania; the University of Botswana and the Ministry
of Health in Gaborone, Botswana; the University of Addis Ababa
and the Federal Democratic Republic of Ethiopia Ministry of
Science and Technology National Health Research Ethics Review
Committee.
Statistical analysis
The LTL distribution is normally distributed with very low skew-
ness (0.27) and kurtosis (0.22). The variance in LTL due to genetic
differences in LTL-related genes in the SSAs was estimated by
first assigning ancestry based on genotypes rather than self-
reported ancestry. Ancestry was inferred using unsupervised
ADMIXTURE analysis (29) based on over 4.1 million SNP geno-
types from a 5 M Omni Illumina array. Individuals were pooled
based on shared ancestry at K = 5 (five genetic ancestral popu-
lations), largely corresponding to linguistic classification [south-
ern Khoesan (San), eastern Khoesan (Hadza), Afroasiatic, Bantu,
Nilo-Saharan]. Individuals of Afroasiatic and Bantu ancestries
resided in two different countries and were coded and analyzed
after grouping by both ancestry and country (seven groups) to
allow for migration or other geographical effects. EAm and AAm
ancestries for subjects in the Family Heart Study were self-
reported, but should be quite accurate based on a previous large
study that included a subset of the Family Heart Study and
validated self-reported ancestry (30). Genotypes were obtained
from an Illumina HumMap550K, Human 6100-Quadv1 or Human
1 M-DuoV3 array for EAms or a Human 1 M-DuoV3 array for
AAms.
For the estimation of age and sex associations with LTL
within and across populations, regression using a general linear
model (GLM) procedure was used (PROC GLM, SAS Inc., Cary, NC,
USA). The combined sub-Saharan population age and sex asso-
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the AAm and EAm populations using GLM. Significance tests
of the age and sex regression coefficients were obtained using
generalized estimating equations (PROC GENMOD, SAS Inc.) and
a compound symmetry variance–covariance matrix estimated
within each population to account for non-independent obser-
vations due to relatedness. When presented separately, the sex
effect was adjusted for age and the age effect was adjusted for
sex. Interactions of sex and age with population were modeled
by cross-products of the two variables, effectively testing for
differing male and female LTL differences among populations or
differing age versus LTL slopes among populations.
To adjust LTL for the total genetic variance, kinship coef-
ficients were first estimated from identical-by-descent (IBD)
estimates calculated from PLINK (31) for all pairs of individu-
als within each of the three population groups. Kinship was
assumed to be zero between groups. Calculations in PLINK were
based on the subset of SNPs in linkage equilibrium (r2 < 0.1
for EAms and SSAs and r2 < 0.2 for AAms) within windows of
100 kb. A different cutoff of linkage disequilibrium (LD) was used
for AAms to include approximately the same number of SNPs
within each window as for the other two populations for the
IBD estimation. The genetic variance–covariance structure of LTL
is estimated as 2 × matrix of kinship coefficients × the additive
genetic variance. The R polygenic_hglm function (32), which is
part of the GenABEL package (33), was used to calculate LTL
residuals from a model including age, sex and the kinship matrix
estimated from pairwise IBD estimates from the study subjects.
The difference between the variance of these residuals and the
total unadjusted LTL variance is the total variance explained by
the model (age, sex and genetics). The LTL variance explained
by age and sex was similarly estimated prior to considering the
genetic data. The significance of the polygenic effect was tested
by comparing −2 times the difference in log-likelihood of the
age- and sex-adjusted models with and without the polygenic
effect.
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